This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Type 2

Starting date:
February 10, 2010
Posting date:
March 15, 2010
Type of communication:
Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Identification number:
RA-2010A70

Reason

Based on new information, complete directions for use including risk statements are required on the labels of some products containing 40mg/dosage unit or more of glucomannan to mitigate throat, esophageal or intestinal obstruction following ingestion of these products.

Depth of distribution

Distributed to health food stores across Canada

Affected products

Type 2

DIN, NPN, DIN-HIM

No Market Authorization

Dosage form

Capsules

Strength

635mg/capsule (containing 250 mg of Glucomannan)

Lot or serial number

3694 2886

Companies

Recalling Firm
Biomed International Products Corp. Unit 102-3738 North Fraser Way Burnaby, British Columbia V5J 5G7
Marketing Authorization Holder
Biomed International Products Corp. Unit 102-3738 North Fraser Way Burnaby, British Columbia V5J 5G7

Date modified: